title: Mucosal mantle cell (centrocytic) lymphomas.
abstract: The morphology, phenotype, genotype and clinical behaviour of four cases of mantle cell lymphoma (centrocytic lymphoma) presenting primarily in mucosa (two gastric, one in large bowel and one tonsillar) are reviewed. Their relationship with the broader group of mantle cell and mucosa-associated lymphoid tissue (MALT) lymphomas is also discussed. All four tumours showed a monomorphic picture of mantle cells (centrocytes) arranged in a diffuse, or vaguely nodular, pattern. Scattered non-neoplastic germinal centres were entrapped within the tumour cells, although there was no follicular colonization. In two cases distinct epithelial infiltration by tumour cells was observed. All four tumours had a CD19, CD20, CD5, IgD, Leu8 immunophenotype, whereas KiM1P and CD10 expression were absent. DRC antibody showed loose aggregates of dendritic cells in three of four cases. Three cases showed PRAD-1/Cyclin D1 overexpression by Northern blot analysis. Although we were not able to detect bcl-1 rearrangement in the major translocation cluster (MTC) breakpoint, the possibility of bcl-1 rearrangement involving other cluster breakpoints cannot be ruled out. The four cases evolved as a disseminated disease, involving either peripheral lymph nodes, spleen or bone marrow. The biological behaviour of mantle cell lymphoma presenting in mucosa appears, irrespective of localization or macroscopic presentation, similar to that of nodal mantle cell lymphoma. Their tendency to dissemination contrasts with MALT lymphomas, which tend to remain localized, and from which mucosa mantle cell lymphoma must be distinguished. The presence of lymphoepithelial lesions does not seem to be a useful differential feature, since occasional epithelial infiltration was seen in two cases. Reactivity with CD5 appears to be especially useful in distinguishing these, since all four cases were clearly positive, in contrast with what is usually found in MALT lymphomas.
authors.affiliation: Department of Pathology, Hospital Clinico, Santiago de Compostela, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Fraga
authors.forename: E
authors.initials: E
authors.lastname: Lloret
authors.forename: L
authors.initials: L
authors.lastname: Sanchez-Verde
authors.forename: J L
authors.initials: JL
authors.lastname: Orradre
authors.forename: E
authors.initials: E
authors.lastname: Campo
authors.forename: F
authors.initials: F
authors.lastname: Bosch
authors.forename: M A
authors.initials: MA
authors.lastname: Piris
mesh_terms: D000368:Aged; D000954:Antigens, Surface / Q000032:analysis; D019938:Cyclin D1; D016213:Cyclins / Q000096:biosynthesis / Q000235:genetics; D005260:Female; D006801:Humans; D007414:Intestinal Neoplasms / Q000473:pathology*; D008207:Lymphatic Metastasis; D018442:Lymphoma, B-Cell, Marginal Zone / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015513:Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics; D013274:Stomach Neoplasms / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D014067:Tonsillar Neoplasms / Q000235:genetics / Q000473:pathology*
chemical_list: D000954:Antigens, Surface; D016213:Cyclins; D015513:Oncogene Proteins; D019938:Cyclin D1